Cleared Special

K140412 - ANS1 SOFTWARE

K140412 is an FDA 510(k) clearance for ANS1 SOFTWARE, manufactured by Ld Technology, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Special 510(k) pathway after a 93-day FDA review.

K140412 · Ld Technology, LLC · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
93d
Days
Class 2
Risk

K140412 is an FDA 510(k) clearance for the ANS1 SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Ld Technology, LLC (Miami, US). The FDA issued a Cleared decision on May 22, 2014 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K140412

510(k) Number K140412 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2014
Decision Date May 22, 2014
Days to Decision 93 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 125d · This submission: 93d
Pathway characteristics
Modification to existing cleared device.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1207
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K140412.
QARDIOARM
K140067 · Qardio, Inc. · Jun 2014
DIGITAL AUTOMATIC BLOOD PRESSURE MONITOR BPM20 SERIES
K140583 · Grandway Technology (Shenzhen) Limited · Jun 2014
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
FORA CARE BLOOD PRESSURE MONITORING SYSTEM
K133588 · Foracare, Inc. · Apr 2014
WITHINGS BLOOD PRESURE MONITOR
K133125 · Withings · Mar 2014
BPROSOFT CASP PC SOFTWARE
K131916 · Healthstats International Pte. , Ltd. · Mar 2014
K140412 · ANS1 SOFTWARE
Download PDF FDA Summary Ld Technology, LLC